ME
Healthcare & Life Sciences
Medipost
South Koreamedi-post.co.kr
Medipost is a Healthcare & Life Sciences startup based in South Korea, most recent round Series C+, 1 tracked investor.
Activeseries-c-plus
series-c-plus
Stage
1
Investors
About Medipost
Based in South Korea, Medipost is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Medipost is a South Korean biotechnology company specializing in stem cell therapeutics, including stem cell banking and the development of advanced stem cell-based treatments for conditions such as osteoarthritis, bronchopulmonary dysplasia, and other diseases.
Explore Medipost's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.